Jagsonpal Pharmaceuticals Ltd News

Jagsonpal Pharma up 7% as co to consider Q2 results, stock-split on Oct 23

The uptick in Jagsonpal Pharma share price came after the company announced that its board of directors will meet on October 23 to consider Q2 and H1FY25 results and proposal for stock-split